Stockreport

Sarepta Therapeutics: Another 'Hold' Call Ahead Of Some Key Catalysts [Seeking Alpha]

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report
PDF The company's gene therapy drug Elevidys faced concerns after a failed confirmatory study, causing a sharp market sell-off. Sarepta plans to push for a full approval [Read more]